Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 9, 2025 • 9:31 AM ET

Date/Time Source News Release
06/30/2025 08:00 AM EDT GlobeNewswire Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live'25
06/11/2025 08:00 AM EDT GlobeNewswire Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis
06/03/2025 08:00 AM EDT GlobeNewswire Chemomab Announces New Patent Awards for Its First-in-Class Agent Nebokitug that is Positioned to Potentially Become the First Approved Drug for Primary Sclerosing Cholangitis
05/15/2025 08:00 AM EDT GlobeNewswire Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update
05/05/2025 08:00 AM EDT GlobeNewswire Chemomab Announces Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis in Distinguished Plenary Session at DDW 2025
04/28/2025 08:00 AM EDT GlobeNewswire Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug's Impact in Primary Sclerosing Cholangitis and Related Diseases
04/21/2025 08:00 AM EDT GlobeNewswire Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences
04/15/2025 08:00 AM EDT GlobeNewswire Chemomab Announces New Medical and Clinical Appointments
03/27/2025 08:30 AM EDT GlobeNewswire Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers
03/06/2025 08:00 AM EST GlobeNewswire New Data Presented at CORA 2025 Conference Highlights Clinical Potential of Chemomab's Nebokitug in Systemic Sclerosis
Page

Additional News

As of July 9, 2025 • 9:31 AM ET

Date/Time Source News Release
06/06/2025 11:52 AM EDT Zacks KURA Stock Rises More Than 15% This Past Week: Here's Why
06/06/2025 11:35 AM EDT Zacks TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy
06/02/2025 10:53 AM EDT Zacks MRK's ADC Drug Combo Shows Antitumor Activity in Lymphoma Study
05/30/2025 10:20 AM EDT Zacks NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study
05/29/2025 10:50 AM EDT Zacks CADL Up as FDA Grants RMAT Status to CAN-2409 in Prostate Cancer
05/28/2025 11:09 AM EDT Zacks RCKT Stock Tanks on Patient Death in Danon Disease Study
05/28/2025 11:07 AM EDT Zacks TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate
05/15/2025 11:26 AM EDT Baystreet Chemomab Hikes on Q1 Figures
05/15/2025 09:22 AM EDT SeekingAlpha Chemomab Therapeutics GAAP EPS of -$0.01 in-line
05/15/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 15th, 2025
Page